VELMANASE ALFA-TYCV

56 reported adverse events

These side effects are most commonly reported by patients taking VELMANASE ALFA-TYCV:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 6
1 PRODUCT COMPLAINT 5
2 PYREXIA 5
3 OFF LABEL USE 4
4 PRODUCT ADMINISTRATION INTERRUPTED 4
5 VOMITING 4
6 ABDOMINAL PAIN 3
7 ARTHROPATHY 3
8 HAEMOGLOBIN DECREASED 3
9 INFUSION RELATED REACTION 3
See all common reactions for VELMANASE ALFA-TYCV

VELMANASE ALFA-TYCV is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TESTICULAR GERM CELL TUMOUR 1 0.0323
1 CONGENITAL MUSCULOSKELETAL DISORDER OF SKULL 1 0.0139
2 ADENOIDITIS 1 0.0079
3 CYSTATIN C INCREASED 1 0.0078
4 GASTROINTESTINAL POLYP 1 0.0030
5 ENDOMETRIAL ABLATION 1 0.0028
6 GASTRIC FISTULA 1 0.0022
7 VASCULAR ACCESS COMPLICATION 1 0.0012
8 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
9 ANTIBODY TEST POSITIVE 1 0.0006
See all enriched reactions for VELMANASE ALFA-TYCV